FINANCE DIRECTOR Experience Finance Director 04/2014 Current Company Name City State Merck Global Capital Investment Planning Reporting. Responsible forecasting, planning reporting Merck Capital Investments (2014 Budget $1.7B) support divisional areas. Harmonize streamline capital project tracking approval procedures. Led total team 12 professionals, Finance Engineering backgrounds. Finance Director 01/2013 03/2014 Company Name City State Americas Merck Consumer Care Mfg Operations Responsible development budgets, forecasts, long range plans, inventory capital reporting manufacturing plants North America (gross spend ~$1B), first 3 months, Latin America Oversaw '14 budget delivered 10% labor overhead standard cost productivity Developed clear, highly collaborative budget COGS review process MCC Finance ensure transparency integrity MCC-specific productivity handoff. Led total team 18 professionals, spanning US, Puerto Rico Canada. Associate Finance Director 04/2011 12/2012 Company Name City State Biologics Product Lifecycle Sourcing BMSC Oversaw development annual budget, quarterly forecasts (total consolidated budget $165M) Biologics Commercialization area, focuses bringing product mfg processes lab scale commercial production scale; analyze financial variances performance trends communicate issues VP, Biologics Mfg Exec Director, BMSC. Provide financial economic analysis support strategic decisions Merck's biologics programs, including production siting analysis (i.e. make vs buy), capital expenditures, market entrance strategies cost reduction initiatives Regularly collaborate influence colleagues multiple areas including Supply Chain Management, Procurement, Marketing, Tax deliver beneficial recommendations Merck Sr. Leadership Serve primary Merck financial liaison key contract manufacturing relationship Lead develop staff 1 Sr. Financial Analyst. Finance Manager 02/2008 03/2011 Company Name City State Merck Manufacturing Division (MMD) Planning, Reporting Analysis Oversaw development MMD annual budget, quarterly forecasts (total consolidated budget $10B, $2B direct P&L impact); analyze financial variances performance trends communicate divisional issues President, Merck Manufacturing direct reports. Established process tools required MMD 5-yr long range operating plan. Process focused major business initiatives/drivers easily scaled incorporate less level detail needed Managed annual budgeting quarterly forecasting MMD's Restructuring program; reviewed performance variances Corporate Finance management external auditors, processed quarterly accelerated depreciation assets totaling $200M across multiple sites Created method calculate manufacturing variances requiring capitalization global basis (impacting 20+ sites); established variance tracking control mechanism ensure balance sheet accuracy support non-current inventory reporting Served primary point contact Corporate Merck divisions; addressed ad-hoc requests regarding audit, statutory management financial reporting business needs Temporarily assumed responsibility MMD HQ Finance team result unexpected 4-month medical leave Director, MMD HQ Finance, leading team 2 analysts. Finance Manager 05/2007 02/2008 Company Name City State Implemented standard financial reporting processes procedures Merck Manufacturing Division. Provided regional financial support North American Latin American plants (~15 sites) annual budget quarterly forecasts; prepared performance summaries variance analyses Senior VP, North Latin American Operations. Coordinated worldwide 2008 budgeting cycle Merck Manufacturing Division, including establishment universal calendars, templates, guidance communications. Supervised staff 3 analysts. Senior Financial Analyst 04/2006 04/2007 Company Name City State Sales Marketing Prepared annual budgets numerous scenario analyses Cordis Neurovascular US Sales WW Marketing groups: ~$20MM spending. Performed budget variance analyses understand drivers spending change Analyzed price-volume mix impact sales performance, well royalties, sales force commissions, product pricing potential contracts sales reserves Simplified methodology managing co-promotion activities another Cordis franchise providing adequate commissions sales force Automated headcount reporting tools using Excel macros. Senior Financial Analyst 06/2004 03/2006 Company Name City State Prepared annual budgets West Point Quality Organization (WPQO) Vaccine Tech Engineering group (VTE): ~$100MM combined spending. Revised monthly financial forecasts based changes business drivers, performed variance analysis presented financial performance metrics WPQO VTE Vice-Presidents direct reports monthly. Implemented new Excel-based models streamline monthly forecast annual budget data collection process. Developed Excel-based headcount reporting model WPQO simplify efforts meet corporate requirements. Financial liaison Six Sigma project team determine lab supply efficiencies. Served Finance Recruiting teams identify talent 2004 2005 National Black MBA Conferences. Senior Internal Auditor 07/2002 06/2004 Company Name City State Evaluated adequacy effectiveness Merck's internal control environment identifying significant business risks conducting detailed testing critical business processes. Supervised audit teams 3-week fieldwork engagements, prepared written reports audit findings recommendations senior management. Completed 11 audit assignments Auditor-in-Charge. Recognized shared best practices improvement throughout Merck's worldwide operations. Participated audits international subsidiaries, divisional entities, corporate, third parties. Developed audit recommendations implementation plans collaboration entity management teams Client Audit Directors order mitigate potential risks. Worked domestic departments international subsidiaries enhance internal control documentation assure Sarbanes-Oxley compliance. Education Master Business Administration Finance May 2002 UNIVERSITY OF MARYLAND COLLEGE PARK Robert H. Smith School Business GPA: GPA: 3.73 Finance GPA: 3.73 Bachelor Arts Chemistry Mathematics Chinese May 1998 NEW YORK UNIVERSITY GPA: GPA: 3.93 UNCF Merck Undergraduate Science Research Scholarship Minorities GPA: 3.93 Chemistry Mathematics Chinese UNCF Merck Undergraduate Science Research Scholarship Minorities Skills streamline, ad, balance sheet, Basic, budgeting, budgets, Budget, business processes, capital expenditures, Cognos, Conferences, contracts, Corporate Finance, cost reduction, Client, data collection, documentation, drivers, economic analysis, Essbase, senior management, Finance, Financial, Financial Analyst, financial forecasts, financial reporting, forecasting, Hyperion, inventory, Investments, JD Edwards, Latin, Leadership, Lotus Notes, Director, macros, managing, Mfg, market, Marketing, MBA, Access, Excel, Microsoft Office Suite, PowerPoint, Win98, Word, pricing, processes, Procurement, promotion, Quality, Recruiting, reporting, Sales, SAP, Sarbanes-Oxley, Six Sigma, Spanish, strategic, Supply Chain Management, Tax, Vaccine, variance analysis, Vista, written